305 related articles for article (PubMed ID: 14744816)
21. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo.
Tea BS; Der Sarkissian S; Touyz RM; Hamet P; deBlois D
Hypertension; 2000 May; 35(5):1069-73. PubMed ID: 10818066
[TBL] [Abstract][Full Text] [Related]
22. Enalapril treatment corrects the reduced response to bradykinin in diabetes increasing the B2 protein expression.
Rastelli VM; Oliveira MA; dos Santos R; de Cássia Tostes Passaglia R; Nigro D; de Carvalho MH; Fortes ZB
Peptides; 2008 Mar; 29(3):404-11. PubMed ID: 18190998
[TBL] [Abstract][Full Text] [Related]
23. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
24. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
Secchi J; Lecaque D; Dunn FW; Jouquey S; Auberval UD; Benzoni F; Sirugue O; Hamon G
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S30-7. PubMed ID: 7527099
[TBL] [Abstract][Full Text] [Related]
25. Role of kinins in the acute antihypertensive effect of enalapril in hypertensive rats.
Salgado MC; Name CF
Braz J Med Biol Res; 1994 Jun; 27(6):1391-401. PubMed ID: 7894353
[TBL] [Abstract][Full Text] [Related]
26. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R
Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903
[TBL] [Abstract][Full Text] [Related]
27. Regulation of mitogenesis by kinins in arterial smooth muscle cells.
Dixon BS; Dennis MJ
Am J Physiol; 1997 Jul; 273(1 Pt 1):C7-20. PubMed ID: 9252437
[TBL] [Abstract][Full Text] [Related]
28. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
[TBL] [Abstract][Full Text] [Related]
29. Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation.
Kuebler JF; Schremmer-Danninger E; Bhoola KD; Roscher AA; Messmer K; Hoffmann TF
Biol Chem; 2003 Sep; 384(9):1311-9. PubMed ID: 14515994
[TBL] [Abstract][Full Text] [Related]
30. Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats.
Damas J; Hallet C; Lefebvre PJ
Br J Pharmacol; 2001 Nov; 134(6):1312-8. PubMed ID: 11704652
[TBL] [Abstract][Full Text] [Related]
31. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
Mathis SA; Criscimagna NL; Leeb-Lundberg LM
Mol Pharmacol; 1996 Jul; 50(1):128-39. PubMed ID: 8700105
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
33. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
34. Bradykinin increases catecholamine release via B2 receptors.
Dendorfer A; Häuser W; Falias D; Dominiak P
Pflugers Arch; 1996; 432(3 Suppl):R99-106. PubMed ID: 8994550
[TBL] [Abstract][Full Text] [Related]
35. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
[TBL] [Abstract][Full Text] [Related]
36. BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2.
Tiritilli A; El Habach T; Haury L; Duret JF
Methods Find Exp Clin Pharmacol; 2004 May; 26(4):247-52. PubMed ID: 15319801
[TBL] [Abstract][Full Text] [Related]
37. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
38. Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction.
Blais C; Lapointe N; Rouleau JL; Clément R; Gervais N; Geadah D; Adam A
Peptides; 2001 Jun; 22(6):953-62. PubMed ID: 11390026
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
40. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
Der Sarkissian S; Marchand EL; Duguay D; Hamet P; deBlois D
Cardiovasc Res; 2003 Mar; 57(3):775-83. PubMed ID: 12618239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
